Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B.
J Med Chem. 2021 Jul 8;64(13):8971-8991. doi: 10.1021/acs.jmedchem.1c00024. Epub 2021 Jun 18.
J Med Chem. 2021.
PMID: 34143631
Free article.
Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity.
Szlávik Z, Ondi L, Csékei M, Paczal A, Szabó ZB, Radics G, Murray J, Davidson J, Chen I, Davis B, Hubbard RE, Pedder C, Dokurno P, Surgenor A, Smith J, Robertson A, LeToumelin-Braizat G, Cauquil N, Zarka M, Demarles D, Perron-Sierra F, Claperon A, Colland F, Geneste O, Kotschy A.
Szlávik Z, et al. Among authors: demarles d.
J Med Chem. 2019 Aug 8;62(15):6913-6924. doi: 10.1021/acs.jmedchem.9b00134. Epub 2019 Jul 24.
J Med Chem. 2019.
PMID: 31339316
Item in Clipboard
Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor.
Szlavik Z, Csekei M, Paczal A, Szabo ZB, Sipos S, Radics G, Proszenyak A, Balint B, Murray J, Davidson J, Chen I, Dokurno P, Surgenor AE, Daniels ZM, Hubbard RE, Le Toumelin-Braizat G, Claperon A, Lysiak-Auvity G, Girard AM, Bruno A, Chanrion M, Colland F, Maragno AL, Demarles D, Geneste O, Kotschy A.
Szlavik Z, et al. Among authors: demarles d.
J Med Chem. 2020 Nov 25;63(22):13762-13795. doi: 10.1021/acs.jmedchem.0c01234. Epub 2020 Nov 4.
J Med Chem. 2020.
PMID: 33146521
Item in Clipboard
Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors.
Weber C, Sipos M, Paczal A, Balint B, Kun V, Foloppe N, Dokurno P, Massey AJ, Walmsley DL, Hubbard RE, Murray J, Benwell K, Edmonds T, Demarles D, Bruno A, Burbridge M, Cruzalegui F, Kotschy A.
Weber C, et al. Among authors: demarles d.
J Med Chem. 2021 May 27;64(10):6745-6764. doi: 10.1021/acs.jmedchem.1c00023. Epub 2021 May 12.
J Med Chem. 2021.
PMID: 33975430
Item in Clipboard
Steady-state pharmacokinetics of amprenavir coadministered with ritonavir in human immunodeficiency virus type 1-infected patients.
Goujard C, Vincent I, Meynard JL, Choudet N, Bollens D, Rousseau C, Demarles D, Gillotin C, Bidault R, Taburet AM.
Goujard C, et al. Among authors: demarles d.
Antimicrob Agents Chemother. 2003 Jan;47(1):118-23. doi: 10.1128/AAC.47.1.118-123.2003.
Antimicrob Agents Chemother. 2003.
PMID: 12499178
Free PMC article.
Clinical Trial.
Item in Clipboard
Single-dose pharmacokinetics of amprenavir coadministered with grapefruit juice.
Demarles D, Gillotin C, Bonaventure-Paci S, Vincent I, Fosse S, Taburet AM.
Demarles D, et al.
Antimicrob Agents Chemother. 2002 May;46(5):1589-90. doi: 10.1128/AAC.46.5.1589-1590.2002.
Antimicrob Agents Chemother. 2002.
PMID: 11959608
Free PMC article.
Clinical Trial.
Item in Clipboard
A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults.
Crémieux AC, Katlama C, Gillotin C, Demarles D, Yuen GJ, Raffi F; AZl10002 Study Group.
Crémieux AC, et al. Among authors: demarles d.
Pharmacotherapy. 2001 Apr;21(4):424-30. doi: 10.1592/phco.21.5.424.34497.
Pharmacotherapy. 2001.
PMID: 11310515
Clinical Trial.
Item in Clipboard
Cite
Cite